We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.14%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,186

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
326
JPMorgan Chase
JPM
$935B
$217K 0.02%
3,200
+1,000
+45% +$65.3K
MKSI icon
327
MKS Inc
MKSI
$20.1B
$217K 0.02%
5,733
+1,297
+29% +$47.2K
MCBK
328
DELISTED
MADISON CNTY FINL INC COM STK (MD)
MCBK
$217K 0.02%
10,310
+9,981
+3,034% +$216K
EXXI
329
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$217K 0.02%
82,364
+54,188
+192% +$199K
GPI icon
330
Group 1 Automotive
GPI
$3.42B
$216K 0.02%
2,374
-2,275
-49% -$194K
HAE icon
331
Haemonetics
HAE
$3.89B
$216K 0.02%
5,239
-371
-7% -$15.6K
MATW icon
332
Matthews International
MATW
$866M
$216K 0.02%
4,068
+2,844
+232% +$145K
AGI icon
333
Alamos Gold
AGI
$11.6B
$214K 0.02%
37,679
+21,131
+128% +$136K
GIII icon
334
G-III Apparel Group
GIII
$1.54B
$214K 0.02%
3,051
+1,825
+149% +$112K
AXS icon
335
AXIS Capital
AXS
$7.68B
$213K 0.02%
+3,999
New +$215K
BMRN icon
336
BioMarin Pharmaceuticals
BMRN
$11.6B
$213K 0.02%
1,555
-2,494
-62% -$309K
FTK icon
337
Flotek Industries
FTK
$852M
$213K 0.02%
2,835
+1,997
+238% +$162K
KW
338
DELISTED
Kennedy-Wilson Holdings
KW
$213K 0.02%
8,645
+5,768
+200% +$148K
NMFC icon
339
New Mountain Finance
NMFC
$651M
$213K 0.02%
14,655
+11,615
+382% +$172K
NVS icon
340
Novartis
NVS
$297B
$213K 0.02%
2,417
+1,524
+171% +$140K
R icon
341
Ryder
R
$9.83B
$213K 0.02%
2,435
+2,414
+11,495% +$228K
KATE
342
DELISTED
Kate Spade & Company
KATE
$212K 0.02%
9,863
+2,133
+28% +$61.7K
SNBR
343
DELISTED
Sleep Number
SNBR
$211K 0.02%
7,048
-1,688
-19% -$53.4K
MNKD icon
344
MannKind Corp
MNKD
$1.21B
$210K 0.02%
7,405
+2,007
+37% +$51.3K
RGLD icon
345
Royal Gold
RGLD
$16.8B
$210K 0.02%
3,413
+3,360
+6,340% +$215K
WOR icon
346
Worthington Enterprises
WOR
$2.75B
$210K 0.02%
11,338
+10,642
+1,529% +$182K
WLL
347
DELISTED
Whiting Petroleum Corporation
WLL
$210K 0.02%
+21
New +$219K
TOWR
348
DELISTED
Tower International, Inc.
TOWR
$209K 0.02%
8,027
+6,851
+583% +$188K
KKD
349
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$209K 0.02%
10,810
+6,201
+135% +$115K
ALV icon
350
Autoliv
ALV
$9.02B
$208K 0.02%
2,476
+1,248
+102% +$110K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,186 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.